Auryxia (ferric citrate) tablets, 210 mg, 200-count bottles, Rx only, Manufactured for and distri...
FDA Recall #D-0170-2021 — Class II — December 9, 2020
Product Description
Auryxia (ferric citrate) tablets, 210 mg, 200-count bottles, Rx only, Manufactured for and distributed by: KERYX BIOPHARMACEUTICALS, INC., One Marina Park Drive, 12th Floor, Boston, MA 02210, NDC 59922-631-01
Reason for Recall
CGMP Deviations
Recalling Firm
Akebia Therapeutics dba Keryx Biopharmaceutials, Inc — Cambridge, MA
Classification
Class II — May cause temporary or medically reversible adverse health consequences.
Product Type
Drugs
Product Quantity
2,170 bottles
Distribution
The product was distributed by two major distributors who further distributed the product nationwide and one specialty pharmacy.
Code Information
Lot Number: 9062, exp. date Feb 2021
Status
Terminated
Voluntary / Mandated
Voluntary: Firm initiated
What Should You Do?
Stop using this medication immediately and contact your pharmacist or doctor. Do not flush medications down the drain. Return the product to the place of purchase for a refund or replacement.